J. Loutit

2.8k total citations
16 papers, 364 citations indexed

About

J. Loutit is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, J. Loutit has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in J. Loutit's work include Cystic Fibrosis Research Advances (6 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Pneumonia and Respiratory Infections (4 papers). J. Loutit is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Pneumonia and Respiratory Infections (4 papers). J. Loutit collaborates with scholars based in United States, Australia and Germany. J. Loutit's co-authors include Lucy S. Tompkins, Stanley Falkow, James Peek, Paul G. Ambrose, Sujata M. Bhavnani, Alan Forrest, Chris Rubino, Patrick A. Flume, Michael N. Dudley and David E. Geller and has published in prestigious journals such as Nature, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

J. Loutit

16 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Loutit United States 11 157 104 85 58 57 16 364
Narges Najafi Iran 10 35 0.2× 44 0.4× 143 1.7× 31 0.5× 94 1.6× 53 319
M.-W. Ho Taiwan 3 64 0.4× 26 0.3× 237 2.8× 61 1.1× 106 1.9× 4 406
Ernest Atlas United States 8 22 0.1× 78 0.8× 96 1.1× 71 1.2× 64 1.1× 11 358
Carmelo Licitra United States 11 36 0.2× 28 0.3× 151 1.8× 41 0.7× 111 1.9× 16 381
Sílvia Capilla Spain 9 80 0.5× 135 1.3× 154 1.8× 88 1.5× 37 0.6× 18 330
L. Franzin Italy 11 31 0.2× 89 0.9× 106 1.2× 58 1.0× 43 0.8× 21 337
Stella Pendle South Africa 11 43 0.3× 32 0.3× 215 2.5× 12 0.2× 198 3.5× 19 361
G Stout United States 5 49 0.3× 46 0.4× 88 1.0× 13 0.2× 228 4.0× 9 293
Takahiro Takuma Japan 10 18 0.1× 32 0.3× 124 1.5× 29 0.5× 101 1.8× 21 275
Caroline Piau France 10 20 0.1× 16 0.2× 63 0.7× 32 0.6× 112 2.0× 27 256

Countries citing papers authored by J. Loutit

Since Specialization
Citations

This map shows the geographic impact of J. Loutit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Loutit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Loutit more than expected).

Fields of papers citing papers by J. Loutit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Loutit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Loutit. The network helps show where J. Loutit may publish in the future.

Co-authorship network of co-authors of J. Loutit

This figure shows the co-authorship network connecting the top 25 collaborators of J. Loutit. A scholar is included among the top collaborators of J. Loutit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Loutit. J. Loutit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bhavnani, Sujata M., David C. Griffith, Olga Lomovskaya, et al.. (2022). Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial Agents and Chemotherapy. 66(12). e0213021–e0213021. 12 indexed citations
2.
Griffith, David C., Sujata M. Bhavnani, J. Loutit, et al.. (2021). Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients. Antimicrobial Agents and Chemotherapy. 65(9). e0260620–e0260620. 15 indexed citations
4.
Elborn, J.S., Douglas Conrad, Shawn D. Aaron, et al.. (2013). WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months. Journal of Cystic Fibrosis. 12. S35–S35. 13 indexed citations
5.
Kearns, Gregory L., Chris Rubino, David C. Griffith, et al.. (2011). 88 Levofloxacin pharmacokinetics (PK) after administration of MP-376 (Levofloxacin inhalation solution; Aeroquin) in children with cystic fibrosis (CF). Journal of Cystic Fibrosis. 10. S23–S23. 19 indexed citations
6.
Flume, Patrick A., David E. Geller, J. Loutit, Michael N. Dudley, & Douglas Conrad. (2011). 87* Effects of inhaled MP-376 (Aeroquin(tm), levofloxacin inhalation solution) on cystic fibrosis patients with both Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) lung infection. Journal of Cystic Fibrosis. 10. S22–S22. 12 indexed citations
7.
Flume, Patrick A., David E. Geller, Doris Staab, et al.. (2010). Effects of inhaled MP-376 (aeroquin, levofloxacin inhalation solution) on lung function in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection. Journal of Cystic Fibrosis. 9. S23–S23. 18 indexed citations
8.
Geller, David E., Patrick A. Flume, David C. Griffith, et al.. (2010). Pharmacokinetics (PK) of aerosol MP-376 (aeroquin; levofloxacin inhalation solution) in CF patients. Journal of Cystic Fibrosis. 9. S23–S23. 10 indexed citations
9.
Rubino, Chris, Sujata M. Bhavnani, Paul G. Ambrose, Alan Forrest, & J. Loutit. (2009). Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults. Pulmonary Pharmacology & Therapeutics. 22(4). 279–285. 72 indexed citations
10.
Engel, Gregory, William F. Fearon, Jon C. Kosek, & J. Loutit. (2000). Pneumocephalus Due to Invasive Fungal Sinusitis. Clinical Infectious Diseases. 30(1). 215–217. 11 indexed citations
11.
Lopez, Fred A., et al.. (1997). Lemierreʼs Syndrome. Southern Medical Journal. 90(6). 640–643. 24 indexed citations
12.
Loutit, J.. (1997). Bartonella infections.. PubMed. 17. 269–90. 8 indexed citations
13.
Peek, James, et al.. (1995). Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells. Infection and Immunity. 63(11). 4553–4556. 103 indexed citations
14.
Loutit, J. & Lucy S. Tompkins. (1991). Restriction enzyme and Southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis. Journal of Clinical Microbiology. 29(12). 2897–2900. 28 indexed citations
15.
Loutit, J.. (1955). Auxotrophic Mutants of Pseudomonas aeruginosa. Nature. 176(4471). 74–75. 2 indexed citations
16.
Loutit, J.. (1952). STUDIES ON NUTRITIONALLY DEFICIENT STRAINS OF PSEUDOMONAS AERUGINOSA. Immunology and Cell Biology. 30(4). 287–294. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026